BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14691564)

  • 21. Phospholipid vesicles interfere with the binding of antibody fragments to the light chain of factor VIII.
    Lewis DA; Bovenschen N; Mertens K; Voorberg J; Ortel TL
    Thromb Haemost; 2005 May; 93(5):833-41. PubMed ID: 15886796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex.
    Yegneswaran S; Mesters RM; Griffin JH
    J Biol Chem; 2003 Aug; 278(35):33312-8. PubMed ID: 12805370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy.
    Dries DR; Newton AC
    J Biol Chem; 2008 Mar; 283(12):7885-93. PubMed ID: 18187412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the anchoring interaction of coagulation factor Va light chain on zeolites: A molecular dynamics study.
    Li J; Chen H; Liu S; Kang Z; Yu L; Liang L; Shen JW; Liu Y; Fan J; Wang Q
    J Colloid Interface Sci; 2022 Feb; 608(Pt 1):435-445. PubMed ID: 34626987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
    Wiencek JR; Na M; Hirbawi J; Kalafatis M
    J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains.
    Pellequer JL; Gale AJ; Griffin JH; Getzoff ED
    Blood Cells Mol Dis; 1998 Dec; 24(4):448-61. PubMed ID: 9880241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of soluble phospholipids in the prothrombinase reaction.
    Stone MD; Nelsestuen GL
    Biochemistry; 2005 Mar; 44(10):4037-41. PubMed ID: 15751980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed structural models of the prothrombinase (FXa-FVa) complex.
    Autin L; Steen M; Dahlbäck B; Villoutreix BO
    Proteins; 2006 May; 63(3):440-50. PubMed ID: 16437549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.
    Orban T; Kalafatis M; Gogonea V
    Biochemistry; 2005 Oct; 44(39):13082-90. PubMed ID: 16185076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine.
    Comfurius P; Smeets EF; Willems GM; Bevers EM; Zwaal RF
    Biochemistry; 1994 Aug; 33(34):10319-24. PubMed ID: 8068668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII.
    Lin L; Huai Q; Huang M; Furie B; Furie BC
    J Mol Biol; 2007 Aug; 371(3):717-24. PubMed ID: 17583728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of the C2 domain of human factor V with a model membrane.
    Mollica L; Fraternali F; Musco G
    Proteins; 2006 Aug; 64(2):363-75. PubMed ID: 16680712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
    Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
    Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
    Zhang X; Rizo J; Südhof TC
    Biochemistry; 1998 Sep; 37(36):12395-403. PubMed ID: 9730811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of amino acid region 334-335 from factor Va heavy chain to the catalytic efficiency of prothrombinase.
    Barhoover MA; Orban T; Beck DO; Bukys MA; Kalafatis M
    Biochemistry; 2008 Jul; 47(26):6840-50. PubMed ID: 18537263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.
    Lü J; Pipe SW; Miao H; Jacquemin M; Gilbert GE
    Blood; 2011 Mar; 117(11):3181-9. PubMed ID: 21156843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the membrane binding mode of the C2 domain of PKC epsilon.
    Corbalán-Garcia S; Sánchez-Carrillo S; García-García J; Gómez-Fernández JC
    Biochemistry; 2003 Oct; 42(40):11661-8. PubMed ID: 14529276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.